The latest update from the FDA emphasizes stricter adherence to good manufacturing practices for biotech companies. This change seems crucial, especially with the increasing scrutiny in our sector. I’m curious to hear how others are preparing for these audits. Are there specific areas you’re focusing on to ensure compliance?